Pfizer: Colonic Neoplasms trials
The registry lists 17 Colonic Neoplasms studies with Pfizer as lead sponsor. 3 are open to participants now and 3 have results posted.
Phase 1 8Phase 2 5Phase 3 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid TumorsNot yet recruitingNCT07897721Phase 1
- A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid TumorsRecruitingNCT07318805Phase 1
- Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal CancerRecruitingNCT07222800Phase 3
- A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal CancerActive, not recruitingNCT04607421Phase 3Results posted
- A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal CancerTerminatedNCT01925274Phase 2Results posted
- Study Of Sunitinib In Combination With Folfox In Patients With Colorectal CancerCompletedNCT00631410Phase 1Results posted
- A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.TerminatedNCT06704724Phase 1
- A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.Active, not recruitingNCT06447662Phase 1
- A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid TumorsTerminatedNCT05983133Phase 1
- A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal CancerActive, not recruitingNCT05217446Phase 2
- A Study of ARRY-438162 (MEK162) in Patients With Advanced CancerCompletedNCT00959127Phase 1
- Study Evaluating Isovorin in Colon CancerCompletedNCT00195585Phase 3
- MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.TerminatedNCT00147550Phase 1/2
- Study Evaluating EKB-569 in Advanced Colorectal CancerCompletedNCT00072748Phase 2
- Study Evaluating MAC-321 in Colorectal CancerCompletedNCT00063427Phase 2
- Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal CancerCompletedNCT00026273Phase 3
- Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal CancerCompletedNCT00004252Phase 3